HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Pfreundschuh Selected Research

Proto-Oncogene Proteins p21(ras)

2/2006Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
5/2002Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Pfreundschuh Research Topics

Disease

45Neoplasms (Cancer)
02/2022 - 01/2002
43Lymphoma (Lymphomas)
08/2021 - 11/2002
31Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 11/2002
28Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2021 - 10/2002
26B-Cell Lymphoma (Lymphoma, B Cell)
02/2022 - 01/2003
19Testicular Neoplasms (Testicular Cancer)
07/2013 - 03/2002
15Multiple Myeloma
01/2019 - 05/2005
10Hodgkin Disease (Hodgkin's Disease)
01/2020 - 01/2002
9Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2018 - 01/2003
8Breast Neoplasms (Breast Cancer)
10/2014 - 12/2003
7Melanoma (Melanoma, Malignant)
01/2013 - 02/2002
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2021 - 04/2006
6Autoimmune Diseases (Autoimmune Disease)
12/2019 - 01/2013
6Monoclonal Gammopathy of Undetermined Significance
07/2011 - 07/2007
5Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021 - 01/2003
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 06/2007
5Infections
07/2015 - 01/2002
5Pancreatic Neoplasms (Pancreatic Cancer)
12/2012 - 05/2002
4T-Cell Lymphoma (Lymphoma, T Cell)
01/2019 - 01/2003
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
09/2015 - 03/2011
3Cardiotoxicity
01/2015 - 12/2005
3Hematologic Neoplasms (Hematological Malignancy)
08/2014 - 03/2011
3Rheumatoid Arthritis
01/2014 - 01/2010
3Adenocarcinoma
12/2012 - 04/2004
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2012 - 01/2003
2Disease Progression
08/2021 - 06/2008
2Viremia
07/2018 - 01/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 04/2011
2Graft vs Host Disease (Graft-Versus-Host Disease)
12/2016 - 06/2014
2Vasculitis (Vasculitides)
05/2016 - 01/2010
2Giant Cell Arteritis (Horton Disease)
05/2016 - 05/2013
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2016 - 05/2013
2Colorectal Neoplasms (Colorectal Cancer)
10/2014 - 06/2003
2Central Nervous System Diseases (CNS Diseases)
07/2014 - 04/2009
2Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
05/2013 - 02/2011
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
05/2013 - 02/2011

Drug/Important Bio-Agent (IBA)

40Rituximab (Mabthera)FDA Link
02/2022 - 11/2002
35Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 01/2002
34Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022 - 01/2002
34AntigensIBA
01/2021 - 03/2002
33Vincristine (Oncovin)FDA LinkGeneric
02/2022 - 01/2002
31Prednisone (Sone)FDA LinkGeneric
02/2022 - 01/2002
21AntibodiesIBA
12/2019 - 03/2002
19Proteins (Proteins, Gene)FDA Link
12/2018 - 07/2003
14Etoposide (VP 16)FDA LinkGeneric
01/2019 - 01/2002
14VaccinesIBA
07/2013 - 03/2002
12EpitopesIBA
08/2021 - 02/2002
10Peptides (Polypeptides)IBA
09/2011 - 02/2002
9ParaproteinsIBA
01/2019 - 07/2007
9Neoplasm Antigens (Tumor Antigens)IBA
12/2012 - 05/2002
8Immunoglobulin G (IgG)IBA
08/2021 - 03/2002
7AutoantibodiesIBA
12/2019 - 01/2013
6Methotrexate (Mexate)FDA LinkGeneric
11/2017 - 01/2002
5ProgranulinsIBA
12/2019 - 01/2013
5Biomarkers (Surrogate Marker)IBA
01/2018 - 06/2011
5Complementary DNA (cDNA)IBA
05/2013 - 03/2002
5Prednisolone (Predate)FDA LinkGeneric
04/2012 - 02/2008
5Monoclonal AntibodiesIBA
02/2011 - 11/2002
5SCP 1IBA
07/2006 - 09/2002
5TESIBA
11/2005 - 05/2002
4AutoantigensIBA
08/2021 - 07/2011
4EnzymesIBA
12/2019 - 02/2006
4Dacarbazine (DIC)FDA LinkGeneric
01/2019 - 01/2002
4Vinblastine (Vinblastine Sulfate)FDA Link
01/2019 - 01/2002
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2018 - 11/2002
4Bortezomib (Velcade)FDA Link
11/2017 - 01/2012
4Biological ProductsIBA
01/2017 - 08/2009
4HLA-A*02:01 antigenIBA
11/2015 - 12/2003
4Bleomycin (Blenoxane)FDA LinkGeneric
09/2009 - 01/2002
4Protein Subunit VaccinesIBA
11/2005 - 12/2003
3ParaffinIBA
08/2017 - 02/2013
3NADPH Oxidases (NAD(P)H oxidase)IBA
01/2015 - 12/2005
3DNA (Deoxyribonucleic Acid)IBA
02/2013 - 10/2009
3HLA-DR Antigens (HLA-DR)IBA
11/2009 - 07/2004
3Procarbazine (Matulane)FDA Link
09/2009 - 01/2002
3Complement System Proteins (Complement)IBA
06/2008 - 03/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 08/2014
2neurabinIBA
01/2020 - 12/2018
2ExotoxinsIBA
01/2020 - 12/2018
2Core Binding Factors (Core-Binding Factor)IBA
01/2018 - 04/2011
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
11/2017 - 08/2016
2Formaldehyde (Formol)FDA Link
08/2017 - 02/2013
2AnthracyclinesIBA
01/2015 - 12/2005
2Vitamin DFDA LinkGeneric
10/2014 - 07/2010
2Messenger RNA (mRNA)IBA
09/2014 - 06/2007
2Estrogens (Estrogen)FDA Link
03/2014 - 04/2008
2Estrogen ReceptorsIBA
03/2014 - 02/2006
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2014 - 01/2009
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2013 - 02/2011
2LigandsIBA
01/2013 - 06/2011
2OsteoprotegerinIBA
01/2013 - 06/2011

Therapy/Procedure

32Therapeutics
01/2019 - 01/2002
28Drug Therapy (Chemotherapy)
02/2022 - 11/2002
19Stem Cell Transplantation
08/2021 - 11/2002
11Radiotherapy
12/2019 - 01/2002
6Transplantation
06/2014 - 01/2006
6Immunotherapy
06/2007 - 02/2002
2Salvage Therapy
01/2019 - 11/2002
2Hematopoietic Stem Cell Transplantation
12/2016 - 06/2007
2Autologous Transplantation
11/2016 - 06/2014